Investor Relations

HTML
Stock Price:   NYSE: BIO  
Scientist using Bio-Rad gel

Helping to Provide a Greater Understanding of Biological Systems and Diseases

Investing in the future of better healthcare for all

A global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare.


Q3 2021 Financial Results


Press Releases

10/15/2021
Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021

08/31/2021
Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference

07/29/2021
Bio-Rad Reports Second-Quarter 2021 Financial Results

View All Press Releases »


Investor Kit

Bio-Rad Dec. 2020 Investor Update Presentation Investor Presentation
Form 10-K 2020 Form 10-K
Proxy Statement 2021 Proxy Statement
Latest Form 10-Q 10-Q

Transfer Agent:
Computershare
c/o Shareholder Services
462 South 4th Street, Suite 1600
Louisville, KY 40202
800-962-4284 (within the U.S.)
781-575-3120 (outside the U.S.)
www.computershare.com